Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | A Sarnaik, HM. Kluger, JA Chesney, J Sethuraman, AVeerapathran, Michelle SA, MT. Lotze, B Larsen, SA. Fischkoff, S Suzuki, L Wang, M Mirgoli, M Fardis, BD. Curti | ||||||||||||
Title | Efficacy of single administration of tumor-infiltrating lymphocytes (TIL) in heavily pretreated patients with metastatic melanoma following checkpoint therapy. | ||||||||||||
|
|||||||||||||
URL | http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.3045 | ||||||||||||
Abstract Text | Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 3045-3045 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Lifileucel | Lifileucel | 0 | 6 |
Lifileucel + Pembrolizumab | Lifileucel Pembrolizumab | 0 | 2 |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|